Literature DB >> 28965297

Discharge destination following hip fracture: comparative effectiveness and cost analyses.

Kristen B Pitzul1, Walter P Wodchis2,3,4, Hans J Kreder2,5, Michael W Carter6, Susan B Jaglal2,3,4,7.   

Abstract

This study determines outcomes and costs of similar hip fracture patients that were discharged from hospital to a rehabilitation facility or to the community within 1 year. Community patients had worse outcomes and lower costs compared to rehabilitation facility patients. This study contributes to understanding hip fracture quality of care.
PURPOSE: The purpose of this study is to determine the impact on mortality and rehospitalization, as well as health system cost, of similar hip fracture patients being discharged to an inpatient rehabilitation facility or directly to the community within 1 year in Ontario, Canada.
METHODS: This was a retrospective study of a propensity-matched cohort completed from the health system perspective. Administrative databases were used to identify and match two groups of older adults (total n = 18,773) discharged alive from acute care for hip fracture repair: patients discharged to inpatient rehabilitation were matched to patients discharged to the community.
RESULTS: A higher proportion of patients discharged to the community (27-42%) died or were rehospitalized (SDhighipr = 0.21, SDlowipr = 0.33) and had substantially lower health system costs (SDhighipr = 0.65, SDlowipr = 0.42) up to 1 year post-acute discharge compared to similar patients discharged to inpatient rehabilitation facilities (IPR) (10-11%).
CONCLUSIONS: This study demonstrates that similar hip fracture patients are discharged to different post-acute settings (i.e., home-based rehabilitation and inpatient rehabilitation) and have different outcomes, thereby calling into question the appropriateness of post-acute rehabilitation delivery in Ontario, Canada. Future research should focus on determining how trade-offs in resource allocation between settings would impact patient outcomes.

Entities:  

Keywords:  Comparative effectiveness; Hip fractures; Post-acute care; Propensity score matching; Rehabilitation

Mesh:

Year:  2017        PMID: 28965297     DOI: 10.1007/s11657-017-0382-8

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  5 in total

1.  Discharge destination following hip fracture in Canada among previously community-dwelling older adults, 2004-2012: database study.

Authors:  L Beaupre; B Sobolev; P Guy; J D Kim; L Kuramoto; K J Sheehan; J M Sutherland; E Harvey; S N Morin
Journal:  Osteoporos Int       Date:  2019-04-01       Impact factor: 4.507

2.  Conceptual Framework for an Episode of Rehabilitative Care After Surgical Repair of Hip Fracture.

Authors:  Katie J Sheehan; Toby O Smith; Finbarr C Martin; Antony Johansen; Avril Drummond; Lauren Beaupre; Jay Magaziner; Julie Whitney; Ami Hommel; Ian D Cameron; Iona Price; Catherine Sackley
Journal:  Phys Ther       Date:  2019-03-01

3.  An update of the prevalence of osteoporosis, fracture risk factors, and medication use among community-dwelling older adults: results from the Canadian Longitudinal Study on Aging (CLSA).

Authors:  Caitlin McArthur; Ahreum Lee; Hajar Abu Alrob; Jonathan D Adachi; Lora Giangregorio; Lauren E Griffith; Suzanne Morin; Lehana Thabane; George Ioannidis; Justin Lee; William D Leslie; Alexandra Papaioannou
Journal:  Arch Osteoporos       Date:  2022-02-04       Impact factor: 2.617

4.  Association Among Cognition, Frailty, and Falls and Self-Reported Incident Fractures: Results From the Canadian Longitudinal Study on Aging (CLSA).

Authors:  Ahreum Lee; Caitlin McArthur; George Ioannidis; Jonathan D Adachi; Lauren E Griffith; Lehana Thabane; Lora Giangregorio; Suzanne N Morin; William D Leslie; Justin Lee; Alexandra Papaioannou
Journal:  JBMR Plus       Date:  2022-09-28

Review 5.  Artificial intelligence in orthopaedics: false hope or not? A narrative review along the line of Gartner's hype cycle.

Authors:  Jacobien H F Oosterhoff; Job N Doornberg
Journal:  EFORT Open Rev       Date:  2020-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.